Jazz Pharmaceuticals to buy cannabinoid medicine developer GW Pharmaceuticals for $7.2B

The company being acquired has developed the first and only FDA-approved prescription cannabidiol medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.